Nathaniel Herzfeld

Array ( [id] => 9183889 [patent_doc_number] => 08623821 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-07 [patent_title] => 'Zymogen activators' [patent_app_type] => utility [patent_app_number] => 13/650958 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 22 [patent_no_of_words] => 37133 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13650958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12367287 [patent_doc_number] => 09957297 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-05-01 [patent_title] => Template-fixed peptidomimetics as inhibitors of FPR1 [patent_app_type] => utility [patent_app_number] => 14/349683 [patent_app_country] => US [patent_app_date] => 2012-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15040 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349683 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815120 [patent_doc_number] => 20130116165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'LIGHT-ACTIVATED FUSION PROTEINS AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/629335 [patent_app_country] => US [patent_app_date] => 2012-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24325 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13629335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9662301 [patent_doc_number] => 08809277 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-19 [patent_title] => 'Dual secured therapeutic peptide delivery system' [patent_app_type] => utility [patent_app_number] => 13/610109 [patent_app_country] => US [patent_app_date] => 2012-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 11 [patent_no_of_words] => 4409 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13610109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920956 [patent_doc_number] => 08486889 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-07-16 [patent_title] => 'Composition and method for the treatment and prevention of endothelial dysfunction' [patent_app_type] => utility [patent_app_number] => 13/573232 [patent_app_country] => US [patent_app_date] => 2012-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9626 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13573232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8883508 [patent_doc_number] => 20130156692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-20 [patent_title] => 'VEGF-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING' [patent_app_type] => utility [patent_app_number] => 13/601023 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 95 [patent_figures_cnt] => 95 [patent_no_of_words] => 29223 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11697594 [patent_doc_number] => 09687491 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-06-27 [patent_title] => 'Compositions and methods of targeting mutant K-Ras' [patent_app_type] => utility [patent_app_number] => 13/601227 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 8057 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777955 [patent_doc_number] => 08853160 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'GLP-1, exendin-4, peptide analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/594313 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 39 [patent_no_of_words] => 26331 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13594313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12112783 [patent_doc_number] => 09868763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-16 [patent_title] => 'Modulators of protease activated receptors' [patent_app_type] => utility [patent_app_number] => 14/235640 [patent_app_country] => US [patent_app_date] => 2012-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 23 [patent_no_of_words] => 31241 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8649558 [patent_doc_number] => 20130035288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'Resorption Enhancers As Additives To Improve The Oral Formulation Of Non-Anticoagulant Sulfated Polysaccharides' [patent_app_type] => utility [patent_app_number] => 13/552569 [patent_app_country] => US [patent_app_date] => 2012-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23215 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13552569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618163 [patent_doc_number] => 20130023475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'C-MET RECEPTOR REGULATION BY ANGIOTENSIN IV (AT4) RECEPTOR LIGANDS' [patent_app_type] => utility [patent_app_number] => 13/547601 [patent_app_country] => US [patent_app_date] => 2012-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 38182 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720923 [patent_doc_number] => 20140256625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'ANTI-AMYLOIDOGENIC, ALPHA-HELIX BREAKING ULTRA-SMALL PEPTIDE THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 14/130983 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 5422 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9491616 [patent_doc_number] => 20140142023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-22 [patent_title] => 'Pharmaceutical Composition for Treating A Metabolic Syndrome' [patent_app_type] => utility [patent_app_number] => 14/232849 [patent_app_country] => US [patent_app_date] => 2012-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12172 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8565945 [patent_doc_number] => 20120328516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'METHOD OF RADIOTHERAPY USING A RADIOLABELLED RGD PEPTIDE' [patent_app_type] => utility [patent_app_number] => 13/533316 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2738 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8523569 [patent_doc_number] => 20120322977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Micropatterned multifunctional inorganic nanoparticle arrays based on patterned peptide constructs' [patent_app_type] => utility [patent_app_number] => 13/507292 [patent_app_country] => US [patent_app_date] => 2012-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3125 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13507292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10837968 [patent_doc_number] => 08865641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways' [patent_app_type] => utility [patent_app_number] => 13/523519 [patent_app_country] => US [patent_app_date] => 2012-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 10939 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13523519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12286141 [patent_doc_number] => 09932369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-03 [patent_title] => Thermosensitive, bioactive biopolymer and associated method of cell harvesting [patent_app_type] => utility [patent_app_number] => 14/123989 [patent_app_country] => US [patent_app_date] => 2012-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 14184 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9173843 [patent_doc_number] => 20130315828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'KIT AND METHOD OF USE OF TARGETING PEPTIDE FOR DIAGNOSIS AND THERAPY OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/478616 [patent_app_country] => US [patent_app_date] => 2012-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7434 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13478616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11218832 [patent_doc_number] => 09447156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Methods and compositions for inhibiting neddylation of proteins' [patent_app_type] => utility [patent_app_number] => 14/118132 [patent_app_country] => US [patent_app_date] => 2012-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 57013 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11016786 [patent_doc_number] => 20160213739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'TREATMENTS FOR DISORDERS USING GUANYLATE CYCLASE C AGONISTS' [patent_app_type] => utility [patent_app_number] => 14/116874 [patent_app_country] => US [patent_app_date] => 2012-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16958 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116874 [rel_patent_id] =>[rel_patent_doc_number] =>)